[HTML][HTML] Anticancer drug resistance: An update and perspective

R Nussinov, CJ Tsai, H Jang - Drug Resistance Updates, 2021 - Elsevier
Driver mutations promote initiation and progression of cancer. Pharmacological treatment
can inhibit the action of the mutant protein; however, drug resistance almost invariably …

Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation

A Queen, HN Bhutto, M Yousuf, MA Syed… - Seminars in Cancer …, 2022 - Elsevier
The primary physiological process of respiration produces carbon dioxide (CO 2) that reacts
with water molecules which subsequently liberates bicarbonate (HCO–3) and protons …

Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer

A Mohanty, A Nam, S Srivastava, J Jones… - Science …, 2023 - science.org
Inherent or acquired resistance to sotorasib poses a substantialt challenge for NSCLC
treatment. Here, we demonstrate that acquired resistance to sotorasib in isogenic cells …

3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation

Y Choi, H Lee, M Ann, M Song, J Rheey, J Jang - Biofabrication, 2023 - iopscience.iop.org
Despite encouraging progress in the development of in vitro cancer models, in vitro cancer
models that simultaneously recapitulate the complexity of the tumor microenvironment and …

Landscape of epithelial–mesenchymal plasticity as an emergent property of coordinated teams in regulatory networks

K Hari, V Ullanat, A Balasubramanian, A Gopalan… - Elife, 2022 - elifesciences.org
Elucidating the design principles of regulatory networks driving cellular decision-making has
fundamental implications in mapping and eventually controlling cell-fate decisions. Despite …

[HTML][HTML] Precision oncology provides opportunities for targeting KRAS-inhibitor resistance

M Sattler, A Mohanty, P Kulkarni, R Salgia - Trends in Cancer, 2023 - cell.com
Novel inhibitors targeting Kirsten rat sarcoma virus homolog (KRAS) KRAS G12C in various
cancers have shown good initial efficacy, but therapy-related drug resistance eventually …

[HTML][HTML] Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies

W Jia, Z Huang, L Zhou, YC Liou, F Di Virgilio… - Drug Resistance …, 2023 - Elsevier
Purinergic signalling, consisting of extracellular purines and purinergic receptors, modulates
cell proliferation, invasion and immunological reaction during cancer progression. Here, we …

A systems biology approach for addressing cisplatin resistance in non-small cell lung cancer

S Ramisetty, P Kulkarni, S Bhattacharya… - Journal of Clinical …, 2023 - mdpi.com
Translational research in medicine, defined as the transfer of knowledge and discovery from
the basic sciences to the clinic, is typically achieved through interactions between members …

Cancer Immunoediting and beyond in 2021

EM Borroni, F Grizzi - International journal of molecular sciences, 2021 - mdpi.com
Human cancer has been depicted as a non-linear dynamic system that is discontinuous in
space and time, but progresses through different sequential states (Figure 1)[1, 2]. Cancer …

Leveraging deep learning algorithms for synthetic data generation to design and analyze biological networks

S Achuthan, R Chatterjee, S Kotnala, A Mohanty… - Journal of …, 2022 - Springer
The use of synthetic data is gaining an increasingly prominent role in data and machine
learning workflows to build better models and conduct analyses with greater statistical …